Inhibitory effects of circulating natural autoantibodies to CD47‐derived peptides on OSCC cells
Objectives Natural autoantibodies serve as an important anti‐tumorigenic component in the body. This study was thus designed to investigate whether circulating natural IgG autoantibodies against a cluster of differentiation 47 (CD47) could exert inhibitory effects on oral squamous cell carcinoma (OS...
Saved in:
Published in | Oral diseases Vol. 29; no. 2; pp. 445 - 457 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Denmark
Wiley Subscription Services, Inc
01.03.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Objectives
Natural autoantibodies serve as an important anti‐tumorigenic component in the body. This study was thus designed to investigate whether circulating natural IgG autoantibodies against a cluster of differentiation 47 (CD47) could exert inhibitory effects on oral squamous cell carcinoma (OSCC).
Subjects and methods
The expression levels of 13 tumor‐targeted genes in three OSCC cell lines were analyzed by qPCR, and CD47 expression in OSCC tissues was also verified with IHC staining. An in‐house ELISA was performed to analyze circulating anti‐CD47 IgG levels in control subjects, oral benign tumor, and OSCC patients, and to detect anti‐CD47 IgG‐abundant plasma. Three OSCC cell lines were treated with anti‐CD47 IgG‐abundant and ‐deficient plasma, respectively, followed by the analysis of cell proliferation, apoptosis, and invasion/metastasis.
Results
The CD47 gene showed the highest expression among 13 genes detected in three OSCC cell lines; its expression was significantly higher in OSCC tissues than adjacent tissues. Plasma anti‐CD47 IgG levels showed the differences between control subjects, oral benign tumor, and OSCC patients. Anti‐CD47 IgG‐abundant plasma could evidently reduce cell viability via suppressing p‐AKT expression and inducing cell apoptosis and inhibit the invasion of all three OSCC cell lines.
Conclusions
Natural autoantibodies against CD47 may be a potential agent for OSCC immunotherapy. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ISSN: | 1354-523X 1601-0825 1601-0825 |
DOI: | 10.1111/odi.13922 |